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Abstract: Bisphenols, particularly bisphenol A (4,4′-(hexafluoroisopropylidene)-diphenol) (BPA),
are suspected of inducing oxidative stress in humans, which may be associated with adverse health
outcomes. We investigated the associations between exposure to bisphenols and biomarkers of
oxidative stress in human studies over the last 12 years (2008-2019) related to six health endpoints
and evaluated their suitability as effect biomarkers. PubMed database searches identified 27 relevant
articles that were used for data extraction. In all studies, BPA exposure was reported, whereas
some studies also reported other bisphenols. More than a dozen different biomarkers were
measured. The most frequently measured biomarkers were 8-oxo-7,8-dihydro-2′-deoxyguanosine
(8-OHdG), 8-iso-prostaglandin F2α (8-isoprostane) and malondialdehyde (MDA), which almost
always were positively associated with BPA. Methodological issues were reported for MDA, mainly
the need to handle samples with caution to avoid artefact formation and its measurements using
a chromatographic step to distinguish it from similar aldehydes, making some of the MDA results
less reliable. Urinary 8-OHdG and 8-isoprostane can be considered the most reliable biomarkers of
oxidative stress associated with BPA exposure. Although none of the biomarkers are considered BPA-
or organ-specific, the biomarkers can be assessed repeatedly and non-invasively in urine and could
help to understand causal relationships.
Keywords: adverse outcome pathway (AOP); analytical methods; antioxidant; bisphenol F (BPF);
bisphenol S (BPS); effect biomarker; HBM4EU; 4-hydroxy-2-nonenal-mercapturic acid (HNE-MA);
reactive nitrogen species (RNS); reactive oxygen species (ROS)
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1. Introduction
Bisphenol A (4,4′-(hexafluoroisopropylidene)-diphenol) (BPA) is an important monomer in the
production of polycarbonate and epoxy plastics, but it is also used in various other applications.
In polyvinylchloride (PVC) plastic, BPA acts as an antioxidant [1]. Due to its high production volume
and migration from plastics, human exposure to BPA is widespread. BPA is suspected for endocrine
(xenoestrogen) disruptive effects in humans and in wild-life (see European Chemical Agency, link:
(https://echa.europa.eu/-/seven-new-substances-added-to-the-candidate-list-entry-for-bisphenol-a-
updated-to-reflect-its-endocrine-disrupting-properties-for-the-environment).The European Food
Safety Authority (EFSA) has established an acceptable daily intake (ADI) of 4 µg/kg body weight per
day [2]. However, studies in animals and cell cultures suggest that BPA can induce oxidative stress [3]
by generating reactive oxygen species (ROS), such as phenoxyl radicals (RO•) [4], the superoxide anion
(O2•−), and hydrogen peroxide (H2O2), presumably through the formation of a reactive o-quinone
radical [5,6] during its metabolism. Endogenously produced ROS can inflict damage to nucleic acids,
proteins and initiate lipid peroxidation in cellular membranes [7], leading to the formation of oxidized
products that, after export into the circulation and excretion into urine, can be used as biomarkers of
oxidative stress, see Figure 1.
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Of the major bases in nucleic acids, guanine is the easiest oxidized base [8]. As an oxidized
nucleoside in the cytosol, inside nuclear and mitochondrial DNA, 8-oxo-7,8-dihydro-2′-deoxyguanosine
(8-oxodGuo or 8-OHdG) is one of the predominant forms of ROS- and free radical-induced lesions
in DNA and has been widely recognized as a biomarker of oxidative stress [7,8]. Various studies
show that urinary 8-OHdG is increased during certain exposures, e.g., smoking and irradiation,
and conditions/diseases such as inflammation. Traditionally, urinary 8-OHdG has been used to
estimate DNA damage in humans after exposure to cancer-causing agents, such as tobacco smoke,
asbestos fibers, heavy metals, and polycyclic aromatic hydrocarbons [9]. Similarly, oxidation of
RNA, which is generally more abundant and less protected than DNA, leads to the formation of
8-oxo-7,8-dihydroguanosine (8-oxoGuo or 8-OHG) [10].
Oxidants can also initiate lipid peroxidation, an oxygen (O2)-driven process generating oxidized
lipids and various reactive aldehydes, such as malondialdehyde (MDA) and 4-hydroxy-2-nonenal
(4-HNE) that can react with cellular macromolecules, including proteins (can result in protein carbonyls)
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and DNA, leading to the formation of adducts [7]. As urinary biomarkers of lipid peroxidation,
8-iso-prostaglandin F2α (8-isoPF2α, 15F2t-isoprostane or 8-isoprostane) derived from arachidonic acid
(Ω-6) and MDA, are commonly measured. The reactive lipid peroxidation product 4-HNE, which
stems from Ω-6 fatty acids, can react with glutathione (GSH) to form 4-hydroxy-2-nonenal-glutathione
(HNE-GSH), which is metabolized into 4-hydroxy-2-nonenal-mercapturic acid (HNE-MA) and excreted
into urine [11].
Plasma sulfhydryl (SH) groups are also susceptible to oxidative damage, which can lower the
available SH groups. Essentially all blood plasma SH groups are protein-associated, although plasma
also contains low amounts of the reduced GSH form [12]. Total thiols represent all available SH groups
in a sample. GSH participates in enzymatic removal of peroxides, forming oxidized glutathione
(GSSG), and GSSG or GSSG/GSH in serum are sometimes used as biomarkers for oxidative stress.
During the continuous turnover of red blood cells, catabolism of hemoglobin results in a steady supply
of bilirubin, which is thought to be a major antioxidant in blood [7].
Reactive nitrogen species (RNS), e.g., peroxynitrite anion (ONOO−) and nitrogen dioxide (NO2),
can react with biomolecules to form adducts, e.g., 8-nitro-guanine (8-NO2Gua) in nucleosides. ONOO−
is formed through the reaction of nitric oxide (NO•) with O2•−. Similarly, RNS can react through
nitration with the phenolic amino acid tyrosine, forming 3-nitro-tyrosine (3-NO2Tyr). Neutrophils
can through myeloperoxidase release the oxidant hypochlorous acid (HOCl), which can react with
tyrosine, forming 3-chloro-tyrosine (3-ClTyr). Oxidation of two nearby tyrosines within proteins can
lead to the formation of o,o’-di-tyrosine (diTyr). Subsequent protein proteolysis releases these modified
amino acids, which are excreted into the urine.
Protein carbonyls, e.g., oxidized amino acids within proteins and/or aldehydes having reacted with
proteins, gene/protein expression profiles (omics-related), and genetic polymorphism, e.g., variants in
antioxidant enzyme coding genes, are also used as biomarkers of oxidative stress [7]. As a consequence
of increased oxidative stress, oxidized products (e.g., 8-OHdG) and expression of protective antioxidant
enzymes are expected to increase, whereas antioxidants will be consumed and are expected to decrease.
Some oxidative stress effect biomarkers, e.g., 8-OHdG, MDA, and 8-isoprostane, have been studied for
decades and are mentioned in several adverse outcome pathways (AOPs) (https://www.aopwiki.org).
However, their use as biomarkers of effect in environmental epidemiological studies investigating the
effects of non-persistent chemicals is more recent.
In a comprehensive review of the BPA literature, we identified various types of effect biomarkers
associated with bisphenol exposure in human studies for the years 2008-2017 [13] as part of the
European Union-funded Horizon 2020 HBM4EU project (website https://www.hbm4eu.eu/). Given
the wide scope of the previous work, it was not possible to analyze in depth all the oxidative stress
biomarkers identified, perform comparisons of analytical methods or discuss potential mechanisms.
Therefore, the present paper has been extended to years 2018-2019 to investigate in more detail the
use of oxidative stress biomarkers in human studies with the aim of also investigate the strengths
and weaknesses of these oxidative stress biomarkers as effect biomarkers of bisphenol exposure.
In addition, the various methods used for measurements of these biomarkers are discussed.
2. Materials and Methods
Terms used in PubMed database searches for bisphenols (BPs) and the six health endpoints
(‘behavior, neurodevelopment, and neurodegeneration’, ‘cancer’, ‘endocrine diseases’, ‘immune
system and allergy’, ‘obesity, metabolic disorders, and cardiovascular diseases’ and ‘reproductive
diseases’) are listed as Table A1 in Appendix A and were selected by a teamwork HBM4EU effort.
Searches were limited to human studies and full-text papers using available filters. Searches took place
at the turn of the year 2017-2018 (limited to years 2008-2017) [13]. On 3 January, 2020, the previous
search was specifically updated for oxidative stress biomarkers until the years 2018-2019. Thus,
the current study covers human references focused on bisphenol-related oxidative stress biomarkers
published between 2008 and 2019. Oxidative stress terms were not specifically searched for, but papers
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mentioning oxidative stress-related measurements in their titles and abstracts were read in detail to
identify oxidative stress effect biomarkers. Only papers that included results on biomarkers of effects
of bisphenols A, AF, F, and S were included, but also other bisphenols are mentioned when measured
in such papers.
Review papers, ex vivo–in vitro and in vitro studies were excluded. Additionally, since some
apparently relevant articles were detected that had not been identified using the search terms for the
six health endpoints, a complementary PubMed search using the broad search terms “bisphenol AND
oxidative stress AND biomarker”, limited to ‘humans’, was performed on 27 January, 2020, without a
time limit.
3. Results
3.1. Literature Search Results
In the first PubMed search for the years 2008-2017, 14 human articles related to bisphenols and
biomarkers of oxidative stress were found [13]. In the second search on 3 January, 2020, using the same
search terms, 10 additional relevant articles for the years 2018-2019 were found, thus, there seems to be
an increasing trend in the number of papers on this topic. The complementary broad search performed
at the end of January 2020 resulted in three additional relevant articles, therefore, in total, 27 articles on
bisphenols and biomarkers of oxidative stress were identified.
3.2. Associations between Bisphenol Exposure and Oxidative Stress Biomarkers in Human Studies
The 27 articles identified on bisphenols and oxidative stress biomarkers were heterogeneous,
regarding study design, the number of participants, healthy vs. patients, oxidative stress biomarker
studied, analytical methods, and results. Therefore, it was not considered appropriate to perform
a meta-analysis. Only seven studies presented data on adverse health outcomes, including
non-alcoholic fatty liver disease (NAFLD), attention deficit hyperactivity disorder (ADHD), autism
(two papers), chronic obstructive pulmonary disease (COPD), infertility, and gynecological complaints
(Table 1). The other papers were grouped into the following categories: pregnant women and their
fetuses/newborns (six papers), children and adolescents (four), adults (seven), elderly (two), and based
on residence area (one). Twenty papers were focused on BPA only, whereas seven papers also included
from 1 to 8 additional bisphenols. For each article, the results related to biomarkers of oxidative stress
were described in the following text and summarized in Table 1.
3.2.1. Diseases and Adverse Health Conditions
In an Italian prospective study by Dallio et al., 2018 [14], non-alcoholic fatty liver disease
(NAFLD) patients (n = 60) were enrolled and further divided into two groups based on absence
or presence of necroinflammation and fibrosis at histology: non-alcoholic fatty liver (NAFL)
patients (n = 30; 54 ± 13 years) with simple lipid accumulation in the hepatocytes, and non-alcoholic
steatohepatitis (NASH) patients (n = 30; 57 ± 11 years), as well as healthy sex-matched controls of both
genders (n = 60; 56 ± 8 years). Among the patients, some also had type 2 diabetes mellitus (T2DM);
the numbers seem to be 11 NAFL and 16 NASH patients (numbers in the article’s text and table do
not match). The levels of BPA were significantly higher in the NAFLD patients compared to controls
in both 24 h urine (p < 0.0001; creatinine-adjusted) and plasma (p < 0.0001). The plasma BPA levels
were significantly higher in NASH patients than in NAFL patients (p = 0.041), independent of the
presence of T2DM. There was also a significant association between BPA plasma levels and the degree
of inflammation evaluated according to Kleiner et al., 2005 [15] as absent, low, moderate, or severe.
On the other hand, urinary BPA levels were lower in NASH versus NAFL patients, although this
difference was not statistically significant (p = 0.201). The NAFLD patients showed higher values
of serum 2-thiobarbituric (TBA) reactive substances (TBARS) (colorimetric analysis, no separation
step used) compared to controls (p < 0.01). Moreover, NASH patients showed higher TBARS levels
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in comparison to NAFL patients, but this result was not statistically significant (p = 0.104). Serum
superoxide dismutase (SOD) and catalase (CAT) activities were greater in the NAFLD group than
in controls (p < 0.01), but the differences between NAFL and NASH patients were not statistically
significant (p = 0.081). An eventual association between BPA and the biomarkers of oxidative stress
(TBARS, SOD, and CAT activities) was not statistically tested, but higher BPA levels in NAFLD patients
were associated with increased TBARS levels as well as higher SOD and CAT activities (all in serum).
After a BPA-free diet for 1 month, NAFLD patients showed a significant reduction in BPA plasma
levels (p = 0.016), without a significant reduction in urine levels (p = 0.221). This resulted in lower
TBARS levels, and lower SOD and CAT activities, in comparison to before the intervention, but not in
a statistically significant manner.
In a Chinese case-control study, Li et al., 2018 [16] measured urinary (morning spot sample) BPA
and 8-OHdG levels in 6-12-year-old children diagnosed with attention deficit hyperactivity disorder
(ADHD) (n = 215) and healthy children (n = 253) living in Guangzhou. Levels were creatinine-adjusted.
The ADHD group had significantly higher urinary BPA (p < 0.001) and 8-OHdG (p < 0.001) levels
vs. controls, and 8-OHdG correlated positively with BPA (r = 0.257, p < 0.001). Younger (6-9 years)
children had higher urinary BPA levels than older (10-12 years) children.
An Egyptian case-control study by Metwally et al., 2018 [17] investigated the role of BPA in
children with autism spectrum disorders (ASD) (n = 49; mean age 5.95 ± 1.91 years) and in age- and
sex-matched controls (n = 40; mean age 5.33 ± 2.28 years). BPA and oxidative stress biomarker analyses
were performed in serum. The results showed that both BPA (p = 0.025) and 8-OHdG (p = 0.0001) were
significantly higher in children with autism, and there were highly significant positive correlations
between both BPA (r = 0.400, p = 0.004) and 8-OHdG (r = 0.805, p = 0.001) with ASD severity. There
was a significant positive correlation between body mass index (BMI) and BPA, but the correlation
between BMI and 8-OHdG was not significant in children with autism.
A Turkish case-control study by Kondolot et al., 2016 [18] aimed at determining levels of plasma
BPA (conjugated plus free form) along with oxidant/antioxidant status in autistic children. BPA and
activities of erythrocyte antioxidant enzymes; glutathione peroxidase (GPx1), thioredoxin reductase
(TrxR), catalase (CAT), superoxide dismutase (SOD), and glutathione reductase (GR), and levels of
erythrocyte antioxidant (GSH) and erythrocyte selenium (Se; co-factor in some antioxidant enzymes),
as well as plasma TBARS (no separation step used) and plasma carbonyl levels, were measured in
autistic children (classic autism (n = 27) and pervasive developmental disorder - not otherwise specified
(PDD-NOS) (n = 10)) vs. controls (n = 35). The mean age was 5.7 ± 2.5 years (males: 80% in study cases
and 78% in controls). The group diagnosed PDD-NOS had higher BPA levels than both the control
(p = 0.003) and classic autism groups (p = 0.003), but the classical autism group did not have significantly
different BPA levels than controls. Carbonyl levels were significantly higher in the combined group
with both classical autism and PDD-NOS) than in controls (p = 0.025). Selenium levels and GPx1,
SOD, and GR activities were higher (p = 0.013; p = 0.002; p = 0.03; p < 0.001, respectively) and CAT
activity was lower (p < 0.001), in the autistic group compared to controls. However, no associations
between BPA concentrations and TBARS or protein carbonyls were found. In addition, no associations
between BPA concentrations and erythrocyte GPx1, TrxR, CAT, SOD, or GR activities, or GSH or Se
levels, were found.
In a Turkish case-control study by Erden et al., 2014 [19], the relationship between chronic
obstructive pulmonary disease (COPD) and BPA, C-reactive protein (CRP), MDA, and total thiol levels
(all in serum) was investigated (COPD: n = 50; 61.6 ± 11.2 years, 44 males/6 females); controls: n = 33;
57.6 ± 11.1 years, 29 males/4 females). In COPD patients, BPA (p < 0.001) and CRP (p = 0.03) levels were
significantly higher than in controls. Total thiol levels (spectrophotometric analysis) were significantly
lower (p = 0.041) in COPD patients than in controls, whereas MDA levels (no high-performance
liquid chromatography (HPLC) separation used before UV analysis) did not differ. Creatinine was
not measured. No correlation between BPA and oxidative stress biomarkers was reported, but a
non-significant linear relationship (p = 0.07) between BPA and CRP was found.
Int. J. Environ. Res. Public Health 2020, 17, 3609 6 of 28
In an Egyptian case-control study by Omran et al., 2018 [20], the association between urinary BPA
levels, based on one spot urine sample during the daytime, and infertility-related factors, i.e., semen
quality and sperm DNA integrity, was investigated in infertile male patients (n = 50) and matched
fertile controls (n = 50) in Upper Egypt. Semen quality evaluated as sperm concentration, morphology,
and motility, and oxidative stress, as total antioxidant activity and MDA levels, were determined along
with sperm DNA damage using the alkaline Comet assay. Seminal cell-free plasma was analyzed for
total antioxidant activity using an H2O2 reaction-based kit, and MDA was measured using TBARS
(no separation step used). Whereas BPA concentrations were similar (with or without creatinine
adjustment), MDA levels were higher (p = 0.012) and total antioxidant levels lower (p = 0.001) in
patients than controls. Overall (n = 100), BPA levels were positively correlated with seminal plasma
lipid peroxidation (r = 0.298, p < 0.01), but slightly negatively correlated with total antioxidant levels
(r = −0.004, p > 0.05), although this effect was not significant. However, effects were significant
for some of the infertile groups subdivided according to the main defects observed that all had
negative correlations.
In a South Korean intervention study (single-blinded randomized clinical trial), Yang et al.,
2014 [21] studied the intake of Korean red ginseng (KRG) associated with BPA in young non-smoking
Korean women with gynecological complaints, mostly menstrual irregularity/pain (KRG: n = 11;
22.91 ± 1.81 years); placebo: n = 11; 22.73 ± 1.68 years). Total BPA from four morning spot urinary
samples taken on day 0, 4, 8, and 14 and MDA (HPLC separation used) were positively associated
(slope = 0.88, r2 = 0.10, p < 0.01). KRG decreased both BPA (p < 0.05) and MDA (p < 0.05) levels.
Creatinine was not measured.
3.2.2. Pregnant Women and Their Fetuses/Newborns
In a nested case-control study, Ferguson et al., 2016 [22] investigated associations between BPA
exposure and oxidative stress and inflammation in pregnant women in the USA (n = 482). Participants
were recruited early in pregnancy and provided urine and plasma at up to four visits (at median 10,
18, 26, and 35 weeks gestation). Total (free + conjugated) BPA, as well as 8-OHdG and 8-isoprostane,
were measured in urine at each visit. Inflammation markers, including C-reactive protein (CRP) and
four cytokines (interleukin (IL)-1β, IL-6, IL-10, and tumor necrosis factor (TNF)-α) were measured
in plasma obtained at the same time points. In adjusted linear mixed models, an interquartile range
(IQR) increase in BPA was associated with significant increases, 5% in 8-OHdG (p = 0.03) and 9% in
8-isoprostane (p = 0.02). In a model adjusted for specific gravity and gestational age at sample collection
(n = 481 subjects, 1519 observations), BPA was significantly associated with increases in 8-OHdG and
8-isoprostane; % change (95% confidence interval (CI)) with IQR increase in BPA was 8.62% (3.93, 13.5;
p < 0.01), and 16.2% (8.61, 24.4; p < 0.01), respectively. The association for 8-OHdG was similar and the
association for 8-isoprostane slightly lower when models were also adjusted for covariates such as
race/ethnicity, education level, health insurance provider, and pre-pregnancy BMI (n = 460 subjects,
1457 observations). Additionally, they observed significantly higher IL-6 concentrations in association
with an IQR increase in BPA (8.95% increase). The authors concluded that these systemic changes
consequent to BPA exposure may mediate adverse birth outcomes and/or fetal development.
A Puerto Rican cohort study with repeated measurements of exposure and outcomes during
pregnancy by Watkins et al., 2015 [23] investigated the relationship between exposure to phenols
and parabens with inflammation and oxidative stress in pregnant women (n = 105) aged 18–40 years
at less than 20 weeks gestation. Spot urinary bisphenol measurements were performed as well
as urinary biomarkers for oxidative stress (measured three times during pregnancy at 16–20,
20–24, and 24–28 weeks of gestation) in 54 subjects (146 measurements) and plasma markers of
inflammation (measured twice during pregnancy at 16–20 and 24–28 weeks of gestation) in 105 subjects
(187 measurements). Linear mixed models were used to assess potential covariates. An IQR increase
in urinary BPA was associated with a 21% higher 8-OHdG (p = 0.001) and 29% higher 8-isoprostane
(p = 0.0002) levels in samples after adjustment for urinary specific gravity, study visit, maternal
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pre-pregnancy BMI, and maternal education. No associations were found between BPA and any of the
markers of inflammation (IL-1β, IL-6, IL-10, TNF-α, or CRP).
In a prospective cohort study with 26-32 weeks of follow-up by Veiga-Lopez et al., 2015 [24],
the impact of BPA on free fatty acids and oxidative stress dynamics was assessed in pregnant women
(n = 24) living in Michigan, USA. After collection of maternal blood at first trimester (gestational weeks
8–14) and pair-matched umbilical cord blood at term, unconjugated BPA (uBPA) and BPA-glucuronide
(BPA-G) were measured in extracted plasma. Thereafter, data were split into low and high uBPA groups
(n = 12 in each) based on maternal levels. Pregnant mothers with high uBPA levels had higher levels of
3-NO2Tyr (p < 0.005) compared with those with low uBPA, although the correlation between uBPA
and 3-NO2Tyr in plasma was not, but nearly, significant (r = 0.398, p = 0.054). In mothers, a significant
Pearson correlation was found between the related BPA-G and 3-NO2Tyr levels (r = 0.440, p < 0.05).
Cord blood from mothers exposed to higher uBPA levels during gestation had higher 3-NO2Tyr levels
compared to the low uBPA group (p < 0.01). Analysis of samples from both groups, low and high uBPA
combined, found a positive correlation between maternal and cord blood 3-NO2Tyr levels (r = 0.475,
p = 0.019). Additionally, 3-ClTyr and diTyr were measured in plasma, but they did not differ between
high and low uBPA exposed mothers or in cord blood. Moreover, no correlation was found with
3-ClTyr and diTyr when combining the low and high uBPA groups. In mothers, high BPA was also
associated with increased palmitic acid (a free fatty acid) in plasma, and palmitic acid correlated
positively with 3-NO2Tyr.
In two cross-sectional studies in a pregnancy cohort with 2-13 weeks of follow-up by
Huang et al., 2017 [25] and 2018 [26] on Taiwanese mother/fetus pairs (total n = 241 [25] and
n = 244 [26]), largely the same study participants were included. In mothers with a live singleton
pregnancy, BPA and biomarkers of oxidative (8-OHdG) and nitrosative (8-NO2Gua) stress and
biomarkers of lipid peroxidation (8-isoprostane and HNE-MA) were measured in maternal urine
collected in the third trimester (gestational age 27–38 weeks). Inflammatory markers CRP, IL-6,
and TNF-α, and antioxidant enzyme glutathione peroxidase (GPx), were measured in maternal and
umbilical cord blood plasma. In adjusted models (oxidative stress biomarkers were normalized to
creatinine levels, whereas BPA, antioxidant, and inflammatory biomarkers were not), a significant
positive association between third-trimester maternal BPA and 8-isoprostane was found (β = 4.5,
p = 0.05), but no association was found between BPA and 8-OHdG, 8-NO2Gua, or HNE-MA. BPA
levels were inversely associated with maternal (β = −30.98, p = 0.04) and cord blood (β = −29.40,
p = 0.01) plasma GPx levels [25]. In the 2018 follow-up study [26], BPA was inversely associated
with penis length (β = −4.43 mm, p = 0.005) among boys who were born to mothers with high levels
of 8-isoprostane.
In a Taiwanese cross-sectional study by Chang et al., 2019 [27] within a pregnancy cohort (the same
as by Huang et al., 2017 [25] and 2018 [26] above) with 2-13 weeks of follow-up, the role of maternal
BPA exposure on birth outcomes through oxidative stress was investigated. Urine was collected
from pregnant women (n = 186; average age 33.3 years) in northern Taiwan in their third trimester
(gestational age 27-38 weeks). Urinary BPA, 8-OHdG, 8-NO2Gua, 8-isoprostane, and HNE-MA were
measured and levels were adjusted to creatinine. A significant, but weak, correlation was observed
between maternal BPA and 8-isoprostane (r = 0.17, p = 0.02), whereas no correlation was found between
BPA and the other biomarkers of oxidative stress. A non-significant trend between increased BPA with
decreased head circumference and birth length was observed. Employing causal mediation analysis
using a directed acyclic graph (DAG), a mediated effect of oxidative stress between BPA exposure and
birth outcomes, e.g., neonatal head circumference, was not observed.
3.2.3. Children and Adolescents
In a Chinese longitudinal cohort study by Zhou et al., 2019 [28], school children (n = 275;
140 boys (50.9%), 135 girls (49.1%)) in East China were investigated for bisphenols and their association
with oxidative damage to nucleosides. At first urine sampling, the children were 7-11 years old
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and follow-ups were carried out one year apart for the next two years (three measurements in
total). Nine BPs (BPA, BPB, BPAF, BPAP, BPE, BPF, BPP, BPS, and BPZ), and 8-OHdG and 8-OHG,
as biomarkers of oxidative DNA and RNA damage, respectively, were measured in first-morning
urine samples. Concentrations of BPs and oxidative damage biomarkers were creatinine-corrected.
Concentrations of 8-OHdG were about 6-fold higher than 8-OHG. A linear mixed model was used for
repeated measures analysis. An IQR, the difference between 25th–75th percentile increase in urinary
BPA, was associated with a 12.9% increase in 8-OHdG (p < 0.001) and a 19.4% increase in 8-OHG
(p < 0.001). The children were mainly exposed to BPA, BPS, BPF, and BPAF, and also an IQR increase of
their sum was associated with a 17.4% increase in 8-OHdG (p < 0.001) and a 25.9% increase in 8-OHG
(p < 0.001). Moreover, BPS was positively associated with 8-OHG (p < 0.006), but not with 8-OHdG.
In a Brazilian cross-sectional study from Rocha et al., 2018 [29], concentrations of
40 endocrine-disrupting chemicals (EDCs) including nine BPs (BPA, BPS, BPAP, BPB, BPP, BPF,
BPAF, BPZ, and BPM) and 8-OHdG were investigated in spot urines from 300 urban resident school
children (aged 6-14 years; 149 males, 151 females) from five geographic regions. Among the bisphenols,
BPA was detected in 98% of the samples. The other bisphenols were found at much lower detection
rates. 8-OHdG was detected in 94.6% of the samples and Spearman rank correlations were found
between urinary concentrations of 8-OHdG and BPA (r = 0.261, p < 0.01) as well as with eight other
EDCs (non-BPs). Clustering of the data based on 14 EDCs to describe exposure, demography (age,
gender, geographical location), and 8-OHdG resulted in two distinct clusters of samples, in which
8-OHdG was the most critical parameter that differentiated the two clusters. The results showed that
co-exposure to BPA and nine other ECDs (non-BPs) was associated with oxidative DNA damage in the
study population.
In a cross-sectional study by Bono et al., 2019 [30], morning urinary sample levels of glucuronic
acid of BPA (GlcA-BPA) and 8-isoprostane were measured in healthy school children (n = 223;
7–19 years old (119 males: 53.4%) living in the town of Chivasso, close to Torino in northern Italy.
Levels were normalized to creatinine. Piecewise linear robust regression identified a statistically
significant association between 8-isoprostane and GlcA-BPA, but only from ≥ 6 ng/mg creatinine
(p < 0.001).
A cross-sectional study by Lv et al., 2016 [31] investigated whether exposure to BPA was associated
with oxidative stress in Chinese children in Guangzhou aged 3-6 years (n = 96; 59 boys, 37 girls).
For single spot urinary BPA and 8-OHdG concentrations, a significant association (p < 0.05, Spearman
rank correlation) in the unit of µg/L was found, but which disappeared after creatinine corrections
(unit of µg/g creatinine). A positive association (r = 0.240, p = 0.016; multiple linear regression) was
found when the µg/L values were transformed to natural logarithms (ln); 1% increase in BPA generated
a 0.15% increase in 8-OHdG.
3.2.4. Adults
In a Chinese cross-sectional study with repeated measurements by Wang et al., 2019 [32], spot
urine samples were collected from non-smoking men (n = 11; 21-28 years old) over a 3-month period.
Participants were asked to collect all urine voids throughout the day and night on days 0, 1, 2, 3, 4, 30, 60,
and 90 (529 out of 535 possible spot samples were collected), giving data on spot samples, first morning
voids and 24 h samples. Urinary BPA, BPF, BPS, 8-OHdG, 8-isoprostane, and HNE-MA were measured
and levels were creatinine-adjusted. The detection rate for BPS was low (13%) and BPS data was not
analyzed further. The results showed that the collection of repeated specimens from each individual is
recommended since a high degree of within-subject variability was found. Elevated urinary levels of
BPA and BPF were associated with increased oxidative stress biomarkers. Urinary BPA was positively
associated with 8-OHdG (r = 0.19, p < 0.001), HNE-MA (r = 0.10, p = 0.03), and 8-isoprostane (r = 0.10,
p = 0.03), whereas BPF was positively associated with HNE-MA (r = 0.11, p = 0.01) and 8-isoprostane
(r = 0.10, p = 0.02), but negatively (not significantly) associated with 8-OHdG (r = −0.05, p = 0.30).
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A cross-sectional South Korean study by Hong et al., 2009 [33] investigated whether various
chemical exposures caused increased oxidative stress in healthy urban residing adults (n = 960; 446 men,
514 women). After adjustment for confounders, e.g., age, sex, weight, smoking, and exercise, urinary
8-OHdG or MDA levels (HPLC separation used) were not associated with BPA levels in single morning
urinary samples. No adjustment was done for creatinine.
In a cross-sectional study on South Korean men (n = 259), premenopausal (n = 92),
and postmenopausal (n = 134) women, BPA exposure was investigated for induction of oxidative stress
and inflammation by Yang et al., 2009 [34]. BPA in single morning urinary samples was significantly
positively associated with urinary MDA (β = 0.056–0.066, p = 0.006–0.008 in three out of three
models after adjustment for confounding factors (HPLC separation used), 8-OHdG (β = 0.072–0.103,
p = 0.008–0.025 in 3 of 3 models) and serum CRP (β= 0.113, p = 0.029 in 1 of 3 models) in postmenopausal
women, but not in men and premenopausal women. Urine concentrations were creatinine-adjusted.
In a cross-sectional Saudi Arabian population study by Asimakopoulos et al., 2016 [35], healthy
persons (n = 130; both genders, aged 1-87 years, median age 35) living in Jeddah were investigated
for associations between 57 xenobiotics (8 BPs: BPA, BPAF, BPAP, BPS, BPF, BPP, BPZ, and BPB) and
oxidative stress in single spot urine samples. After creatinine adjustment of urinary BPs and 8-OHdG
concentrations, BPA (r = 0.38, p < 0.0001) and BPS (r = 0.30, p < 0.0005) were significantly associated
with 8-OHdG. In addition, all eight BPs together were positively associated (r = 0.43, p < 0.0001)
with 8-OHdG.
In a cross-sectional Singaporean study, paired indoor dust and urine samples were collected from
healthy participants (n = 33; 20 men and 13 women, aged 22-37 years) by Liu et al., 2019 [36]. BPA,
BPS, and various bisphenol A diglycidyl ethers (BADGEs) were measured. Single morning urinary
sample levels of BPA and oxidative stress were adjusted for specific gravity. The results showed that
8-OHdG levels in urine samples were positively correlated with urinary BPA levels (r = 0.353, p < 0.05)
and BMI (r = 0.431, p < 0.05), suggesting that elevated oxidative stress might be associated with BPA
exposure and obesity.
In a South Korean cross-sectional study by Choi et al., 2019 [37], serum and single spot urine
samples were collected from adult Koreans (n = 1000; 17-70 years old, ≈50% of each sex) with the
objective of measuring BPA and serum bilirubin (antioxidant). After the exclusion of participants
below 20 years of age, serum samples with too low serum volume and urinary samples with too
high creatinine concentration, 709 urine and 752 serum samples remained. After analysis, serum
samples with too low chemical concentrations were also excluded, as were samples for which several
analytical parameters were missing, leaving 585 urinary and 465 serum samples. After enzymatic
hydrolysis of conjugated BPA, total concentrations of BPA were measured in urine and serum. Urinary
concentrations were adjusted for creatinine. Multivariate regression identified an inverse association
between urinary BPA and serum bilirubin levels (β = −0.071, p < 0.0001), whereas no association was
found between serum BPA and serum bilirubin.
In a South Korean intervention study by Yi et al., 2011 [38], young non-smoking women (n = 14;
age 24.4 ± 4.0 years) were given wheat sprout juice for 14 days and the effects on BPA levels and
oxidative stress were investigated. Total urinary BPA levels, based on first voids of morning urine
sampled on days 0, 3, 7, and 14 of intervention, were positively associated with urinary 8-OHdG levels
(slope = 1.47, p = 0.18 (not significant)), as well as with urinary MDA levels (HPLC separation used)
(slope = 0.85, p = 0.03). Levels of BPA, but not 8-OHdG and MDA, were creatinine-adjusted. Wheat
sprout juice intake lowered urinary BPA levels (p = 0.02) as well as 8-OHdG and MDA levels, although
not significantly.
3.2.5. Elderly
Two South Korean prospective cohort studies with repeated measurements by the same group,
Kim et al., 2016 [39], and Kim and Hong, 2017 [40], investigated the role of genetic polymorphisms
in oxidative stress-related genes on BPA exposure in elderly Koreans. Urine samples for BPA
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measurements were collected during up to five visits from the subjects for two years, out of which
many participated in both studies. Blood samples for genotyping were collected at three time points.
The repeated measurements were analyzed using GLIMMIX models. In the first study, Kim et al.,
2016 [39] investigated the relationship between BPA exposure, liver function, and modification of
genetic polymorphisms in oxidative stress-related genes in elderly (≥60 years, mean age 70.6, n = 471;
122 (25.9%) men, 349 (74.1%) women). Genomic DNA from human peripheral blood lymphocytes
was analyzed for single nucleotide polymorphisms (SNPs) in cyclooxygenase 2 (COX2 or PTGS2),
epoxidehydrolase 1 (EPHX1), catalase (CAT), and superoxide dismutase 2 (SOD2 or MnSOD) genes.
Significant associations, as significant odds ratios, of BPA with abnormal liver function were reported
in Koreans with certain polymorphisms in genes associated with oxidative stress, such as COX2, CAT,
EPHX1, and SOD2.
In the second study, Kim and Hong, 2017 [40] further investigated whether BPA exposure induced
oxidative stress as MDA in elderly Koreans (≥60 years, mean age 70.8, n = 548; 142 (25.9%) men,
406 (74.1%) women) and extended the battery of analyzed oxidative stress-related gene polymorphisms
to COX2, EPHX1, heat shock protein 70-hom (HSP70-hom), paraoxonase 1 (PON1), endothelial nitric
oxide synthase (eNOS), CAT, dopamine receptor D2 (DRD2), SOD2, and myeloperoxidase (MPO).
After adjusting for covariates, but not creatinine, a significant positive association was found between
urinary BPA and MDA (HPLC separation used) in both male and female participants (males: β = 0.19
and p = 0.0003; females: β = 0.18 and p < 0.0001; total: β = 0.18 and p < 0.0001) regardless of any
genotype of the nine oxidative stress-related genes.
3.2.6. Exposures Based on Residence Area
In a Chinese cross-sectional study by Zhang et al., 2016 [41], it was investigated if exposure
to eight different bisphenols (BPA, BPAF, BPAP, BPS, BPF, BPP, BPZ, and BPB) in persons aged
0.4–87 years (n = 116; 66 males, 50 females) living near an e-waste recycling region in Longtang Town,
Qingyuan City, China, or in rural (80 km northwest of Longtang, n = 22) or urban (Guangzhou, 60 km
southeast of Longtang, n = 20) reference areas displayed increased oxidative stress. In urinary samples
based on first morning voids, BPA, BPS, and BPF were detected with frequencies >90% in persons living
near e-waste facilities, with geometric mean concentrations of 3.75, 0.469, and 0.435 µg/g creatinine,
whereas these values were 1.78, 1.51, and 1.12 µg/g creatinine in the urban reference area and 1.52, 1.03,
and 0.219 µg/g creatinine in the rural reference area, for BPA, BPS, and BPF, respectively. The other five
bisphenols were rarely found regardless of sampling location. In the e-waste dismantling location,
urinary 8-OHdG was significantly and positively correlated with urinary BPA (r = 0.413, p < 0.001)
and PBS (r = 0.398, p < 0.001), but not with BPF (r = 0.118, p = 0.208). Concentrations of bisphenols,
but not 8-OHdG, were creatinine-adjusted. Similar correlations between 8-OHdG and BPA and BPS,
but not BPF, were also observed when using combined data from the two reference areas.
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* Abbreviations: attention deficit hyperactivity disorder (ADHD), autism spectrum disorders (ASD), bisphenol A diglycidyl ethers (BADGEs), bisphenol A
(4,4′-isopropylidenediphenol) (BPA), bisphenol AF (4,4′-(hexafluoroisopropylidene)-diphenol) (BPAF), BPA glucuronide (BPA-G), bisphenol AP (4,4′-(1-phenylethylidene)bisphenol)
(BPAP), bisphenol B (2,2-Bis(4-hydroxyphenyl)butane) (BPB), bisphenol E (1,1-bis(4-hydroxyphenyl)ethane) (BPE), bisphenol F (4,4′-dihydroxydiphenylmethane) (BPF), bisphenol
M (4,4′-(1,3-phenylenediisopropylidene)bisphenol) (BPM), bisphenol P (4,4′-(1,4-phenylenediisopropylidene)bisphenol) (BPP), bisphenol S (4,4′-sulfonyldiphenol) (BPS), bisphenol
Z (4,4′-cyclohexylidenebisphenol) (BPZ), catalase (CAT), catalase gene (CAT), 3-chloro-tyrosine (3-ClTyr), chronic obstructive pulmonary disease (COPD), cyclooxygenase 2 gene
(COX2), C-reactive protein (CRP), o,o’-di-tyrosine (diTyr), deoxyribonucleic acid (DNA), dopamine receptor D2 gene gene (DRD2), endocrine-disrupting chemicals (EDCs), endothelial
nitric oxide synthase gene (eNOS), epoxidehydrolase 1 gene (EPHX1)glucuronic acid of BPA (GlcA-BPA), glutathione peroxidase (GPx, GPx1), glutathione reductase (GR), glutathione
(GSH), 4-hydroxy-2-nonenal-mercapturic acid (HNE-MA), heat shock protein 70-hom gene (HSP70-hom), interleukin 1β (IL-1β), interleukin-6 (IL-6), interleukin-10 (IL-10), interquartile
range (IQR), 8-iso-prostaglandin F2α (8-isoprostane), Korean red ginseng (KRG), malondialdehyde (MDA), myeloperoxidase gene (MPO), non-alcoholic fatty liver disease (NAFLD),
non-alcoholic fatty liver (NAFL), non-alcoholic steatohepatitis (NASH), 8-nitro-guanine (8-NO2Gua), 3-nitro-tyrosine (3-NO2Tyr), 8-oxo-7,8-dihydro-2′-deoxyguanosine (8-OHdG),
8-oxo-7,8-dihydroguanosine (8-OHG), pervasive developmental disorder—not otherwise specified (PDD-NOS), paraoxonase 1 gene (PON1), selenium (Se), single nucleotide polymorphisms
(SNPs), superoxide dismutase (SOD), superoxide dismutase 2 gene (SOD2), 2-thiobarbituric (TBA) reactive substances (TBARS), tumor necrosis factor α (TNF-α), thioredoxin reductase
(TrxR), unconjugated BPA (uBPA).
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Only seven papers had looked at associations between bisphenols, oxidative stress biomarkers,
and a specific health outcome (Table 1). NAFLD patients had higher plasma and urine BPA and
TBARS levels and SOD and CAT activities versus controls [14]. Children with ADHD had higher
BPA and 8-OHdG levels vs. controls [16]. Children with ASD had higher BPA and 8-OHdG than
controls, and both parameters correlated positively with ASD severity [17]. The other study on autism
in children found that the group with a pervasive developmental disorder – not otherwise specified
(PDD-NOS), but not the group with classic autism, had higher BPA levels than controls, carbonyl levels
were significantly higher in the combined group with both classical autism and PDD-NOS than controls,
and selenium levels and GPx1, SOD, and GR activities were higher and CAT activity was lower in the
autistic group compared with controls [18]. However, no associations between BPA concentrations and
TBARS, protein carbonyls, erythrocyte GPx1, TrxR, CAT, SOD, or GR activities, or GSH or Se levels, were
found [18]. COPD patients had higher BPA concentrations in serum, but lower total thiol levels than
controls and serum MDA did not differ between the groups [19]. In infertile men, BPA concentrations
were similar, MDA levels higher, and total antioxidant levels lower than in controls, and overall
BPA levels correlated positively with seminal plasma lipid peroxidation [20]. In young women with
gynecological complaints, urinary total BPA and MDA levels were positively associated [21].
Overall, the 27 studies point towards an association between BPA and oxidative stress, based
particularly on the 8-OHdG and 8-isoprostane biomarkers (Table 2). Most of the studies on 8-OHdG,
mainly measured in urine, only one in serum, found a positive association, although a few studies
also found no associations. In addition, the related single study on 8-OHG in urine found a
positive association. A few 8-OHdG studies can be interpreted as equivocal (positive, or no
association, depending on how the analyses were performed), but none found a negative association.
For 8-isoprostane, all five studies (all in urine), with the three Taiwanese pregnancy studies performed
on the same cohort counted as one, found a positive correlation. Additionally for MDA, when using
a separation step before analysis, more studies reported positive associations than reported no
associations. For the other oxidative stress biomarkers, including unspecific MDA analysis and
other aldehydes using TBARS, the outcomes were more mixed and studies were too few to conclude.
With increased oxidative stress levels, antioxidant enzymes would be expected to increase. Thus,
that Huang et al., 2017 [25] found a negative association between GPx and BPA was the only effect
association among the papers that went in an opposite direction in terms of oxidative stress. However,
the use of antioxidant enzyme levels as biomarkers of oxidative stress is somewhat uncertain since
they may also participate in other reactions or be time-dependent. BPA was most often detected and
reported, followed by BPF and BPS as the second most frequently measured BPs, although in few
studies. Thus, dominantly positive associations, but also some equivocal results, but only one negative
association, were found between BPA and oxidative stress biomarkers.
Table 2. Summary of positive, equivocal, and negative statistical associations between BPA and
oxidative stress biomarkers in human studies.
POSITIVE NO ASSOCIATION NEGATIVE 1
8-OHdG 2
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Dallio 2018 (serum TBARS)
Omran 2018 (seminal plasma)
Kondolot 2016 (plasma TBARS)
Erden 2014 (serum) -
HNE-MA
Wang 2019 (urine) Huang 2017 and 2018, and Chang2019 (urine) -
8-NO2Gua
- Huang 2017 and 2018, and Chang2019 (urine) -
Antioxidant enzymes
Dallio 2018 (serum SOD and CAT) Kondolot 2016 (erythrocytes) Huang 2017 (maternalplasma and cord blood (GPx)
Total thiols and GSH
- Kondolot 2016 (erythrocytes) -
- Erden 2014 (serum) -
Oxidative stress genetic polymorphism (DNA)
Kim 2016 (association BPA vs. liver function for
certain oxidative stress genes) - -
3-NO2Tyr
Veiga-Lopez 2015 (plasma) - -
3-ClTyr (plasma) and diTyr
- Veiga-Lopez 2015 (plasma) -
8-OHG
Zhou 2019 (urine) - -
Bilirubin (serum)
- Choi 2019 (serum) Choi 2019 (urine)
Protein carbonyls
- Kondolot 2016 (plasma) -
Total antioxidant activity (no significant outcomes)
- - -
1 For antioxidants (consumed during oxidative stress), but not antioxidant enzymes, a negative statistical
association with BPA is regarded as positive in terms of effects on health due to oxidative stress. 2 Abbreviations:
bisphenol A (4,4′-isopropylidenediphenol) (BPA), catalase (CAT), 3-chloro-tyrosine (3-ClTyr), o,o’-di-tyrosine (diTyr),
deoxyribonucleic acid (DNA), glutathione peroxidase (GPx), glutathione (GSH), 4-hydroxy-2-nonenal-mercapturic
acid (HNE-MA), 8-iso-prostaglandin F2α (8-isoprostane), malondialdehyde (MDA), 8-nitro-guanine (8-NO2Gua),
3-nitro-tyrosine (3-NO2Tyr), 8-oxo-7,8-dihydro-2′-deoxyguanosine (8-OHdG), 8-oxo-7,8-dihydroguanosine (8-OHG),
positive (POS), superoxide dismutase (SOD), 2-thiobarbituric (TBA) reactive substances (TBARS). 3 Source of the
oxidative stress biomarker (often the same as for BPA, see Table 1).
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3.3. Suggestions of Analytical Methods for the Identified Biomarkers of Oxidative Stress and Evaluation of Their
Strengths and Weaknesses
The most frequently measured biomarkers of oxidative stress in human bisphenol studies over the
last 12 years were 8-OHdG, 8-isoprostane, and MDA. Our suggestions of suitable analytical methods
and strengths and weaknesses of each biomarker are described in Table 3. However, several factors
influence choosing the analytical method, e.g., availability of instrumentation and commercial kits,
need for derivatization (particularly for small hydrophilic molecules that are poorly retained by the
separating column), availability of standards (often isotopically labeled for mass spectrometry), desired
specificity and sensitivity, research budget, personal skills, etc. Most of the small molecule biomarkers
in Figure 1 can be detected using liquid or gas chromatography-mass spectrometry (LC-MS or GC-MS)
and these methods were also the most common choices in the included articles. Tandem MS (i.e.,
LC-MS/MS and GC-MS/MS) offers extra high sensitivity but is also a large investment.
Table 3. Evaluation of analytical methods and strengths and weaknesses of the identified biomarkers
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1 The three Taiwanese studies on the same pregnancy cohort [25–27] had recruited subjects during a similar time
period and observed largely the same outcomes regarding 8-isoprostane, 8-OHdG, 8-NO2Gua, and HNE-MA, and are
therefore counted as one study; 2 Abbreviations: bisphenol A (4,4′-isopropylidenediphenol) (BPA), (3-chloro-tyrosine
(3-ClTyr), o,o’-di-tyrosine (diTyr), deoxyribonucleic acid (DNA), enzyme-linked immunosorbent assay (ELISA),
gas chromatography-mass spectrometry (GC-MS), glutathione (GSH), 4-hydroxy-2-nonenal-mercapturic acid
(HNE-MA), hydrogen peroxide (H2O2), hypochlorous acid (HOCl), high-performance liquid chromatography
with electrochemical detection (HPLC-EC), 8-iso-prostaglandin F2α (8-isoprostane), liquid chromatography-mass
spectrometry (LC-MS), malondialdehyde (MDA), 8-nitro-guanine (8-NO2Gua), 3-nitro-tyrosine (3-NO2Tyr),
8-oxo-7,8-dihydro-2′-deoxyguanosine (8-OHdG), 8-oxo-7,8-dihydroguanosine (8-OHG), polymerase chain reaction
(PCR), reactive nitrogen species (RNS), reactive oxygen species (ROS), sulfhydryl (SH), 2-thiobarbituric (TBA)
reactive substances (TBARS), ultraviolet (UV).
4. Discussion
Overall, the identified studies indicated that exposure to BPA was positively associated with
increased urinary levels of 8-OHdG, MDA, and 8-isoprostane. However, there were also some studies
that found no associations, or that were equivocal for some of the oxidative stress effect biomarkers.
Notably, only one study (on GPx) reported a negative association in terms of effect biomarkers of
oxidative stress (note that a negative statistical association between BPA and antioxidants shall be
regarded as a positive association in terms of effects on the health of oxidative stress). Since the
mentioned oxidative stress biomarkers in serum are ultimately excreted in the urine, measurement in
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urine is preferred over serum or plasma. Moreover, urine samples can be obtained repeatedly due to
their non-invasiveness, offering the advantage of evaluating exposure to bisphenols and oxidative
stress biomarkers throughout time.
Analysis of MDA generally relies on reaction with 2-thiobarbituric acid (TBA) under heating
(30-60 min., 70-100 ◦C) where artefactual formation of MDA or other aldehydes can take place [42,43].
TBA will also react with other aldehydes (altogether called TBA reactive substances (TBARS), and
TBA-MDA products should, therefore, be analyzed using a separation method such as HPLC [42,44],
but this is not always the case, e.g., when commercial kits based only on colorimetric detection are used.
Therefore, the use of MDA as an oxidative stress biomarker can be questioned as the obtained results
are less reliable if a separation step is not included in the analytical procedure. MDA can also be
measured using gas chromatography-mass spectrometry (GC-MS) after derivatization under milder
conditions [43,45]. Accounting for the unclarity regarding how much artefactual MDA is formed
during MDA derivatization, and that some studies have not performed HPLC separation of the formed
TBA2-MDA complex prior to analysis, urinary 8-OHdG and 8-isoprostane appear to be the most
suitable effect biomarkers of oxidative stress.
As a limitation, however, these biomarkers are not specific for BPA, and serum/urinary oxidative
stress biomarkers are often not specific to a certain organ. They may also be formed in foods (reacting
with proteins and DNA) and not in the body and are therefore unspecific for BPA exposure.
Regarding the other biomarkers, the single study having measured both 8-OHdG and 8-OHG [28]
found a stronger association between BPA, or the sum of the four most dominant BPs, and 8-OHG
compared with 8-OHdG, despite lower levels of 8-OHG. Urinary HNE-MA has the potential for
becoming a reliable biomarker of lipid peroxidation, however, yet there are few studies available.
Increased antioxidant enzyme activities of e.g., CAT and SOD, most likely reflect increased ROS levels
but are not proof of oxidative damage. Lowered antioxidant levels can result from oxidative stress
although some antioxidants, e.g., GSH, also get depleted in enzymatic reactions unrelated to oxidative
stress. GSSG or GSSG/GSH in serum is sometimes used as a biomarker for oxidative stress. However,
GSH also acts as an electron donor in several biochemical processes, limiting the specificity not only
to oxidative stress. Few studies have investigated the relationship between BPA and biomarkers of
nitrosative stress. Regarding RNS, which can be seen as a type of ROS, one study found an association
between 3-NO2Tyr and BPA [24], but more studies are needed to confirm this finding. There seems
to be no clear mechanism yet for how bisphenols would lead to increased RNS (e.g., ONOO−, NO2),
but it may be due to increased levels of O2•− caused by bisphenols, that subsequently react with NO•,
forming ONOO−. For the other RNS generated biomarkers, no associations with bisphenols were
found, but there was only a single study.
Nearly half of the included studies (12 of 27) had a cross-sectional design, which does not allow
the assessment of cause and effect relationships because the exposure and the health outcomes are
measured in the study participants at the same time. Therefore, a causal association between the
exposure to bisphenols and oxidative stress and further to the various health outcomes cannot be
established with certainty based on the cross-sectional studies. Many of the oxidative stress biomarkers
(Table 3) are not organ-specific, and for this reason, they are also difficult to link to a certain disease.
Prospective studies are needed and may also include mediation analyses. The role of oxidative stress
as a link between BPA exposure and specific health outcomes can be evaluated using mediation
analysis as was done by Chang et al. (2019) using DAG [27]. Broadly, mediation analysis estimates the
potential indirect effect exerted by a mediatory variable in the causal path between a given exposure
and outcome [46].
Only seven papers had looked at associations between bisphenols, oxidative stress biomarkers,
and a specific health outcome (Table 1). One study had a prospective cohort design, five were
case-control studies and one study was a single-blind randomized clinical trial. They all found higher
levels of BPA and various oxidative stress biomarkers in the patient groups versus the controls group,
or a positive correlation between BPA levels and oxidative stress biomarker levels in the patient group.
Int. J. Environ. Res. Public Health 2020, 17, 3609 21 of 28
However, since only one, or two studies on autism in children, were found, no firm conclusions can be
drawn on the causal link between BPA, oxidative stress, and these health outcomes.
Several of the measured biomarkers of oxidative stress are implicated in adverse outcome
pathways (AOPs), mostly as key events (KEs), and rarely linked to a specific adverse outcome (AO)
(see Appendix B). Specifically, none of the oxidative stress biomarkers found in these studies were
listed in AOPs linked to any of the health outcomes included in our literature search (Appendix A).
In these human studies, exposure is often estimated from measurements of the substances in the
urine, often only from one spot urine sample per person and/or time point, and will therefore not
take into account the within-person variability in urine concentrations [47]. Non-persistent chemicals
such as bisphenols have short physiological half-lives, and thus, a single measurement cannot provide
information on long-term exposures. The reported bisphenol exposures in the summarized studies
will therefore not necessarily reflect the real-life exposures. Sun et al. [47] concluded that the urinary
excretion of various biomarkers such as BPA is reasonably reproducible in 24-h urine samples that are
collected within a few days or ≤1 year, and that three 24-h samples are sufficient for the measurement
of long-term exposure status in epidemiologic studies. Another paper showed that for non-persistent
chemicals, collecting and pooling three samples per day instead of all daily samples, efficiently estimates
exposures over a week or more [48]. Urinary BPA levels were in the low µg/L urine range except
for one study [21] that reported low ng/L urine levels (likely an error as a figure showed µg/L units).
Interestingly, one study [30] found that oxidative stress may first begin at a certain BPA threshold
(from BPA-G ≥ 6 ng/mg creatinine).
The various studies differ in whether and how adjustment for urinary dilution was done. Some
studies analyzed uncorrected data, e.g., units inµg/L, whereas others normalized the urine concentrations
to the concentration of creatinine, a muscle breakdown product, or to specific gravity, the ratio of
densities between a urine sample and pure water. No study analyzed urine osmolality. As discussed
elsewhere [49], adjustment for urinary dilution is recommended to obtain reliable urinary concentrations
of BPA or oxidative stress biomarkers, but there is currently no consensus on the most appropriate
method, although some recent studies have concluded that specific gravity is superior to creatinine [49].
Urinary concentrations can be ‘standardized’ or ‘corrected for’ (e.g., µg/g creatinine) or ‘adjusted for’ as
a covariate in statistical models (i.e., creatinine set as an independent variable when performing multiple
regression analysis; units remain as µg/L) [49]. Both approaches were used in the studies included in
this paper. Notably, if X-Y type analysis, e.g., BPA vs. 8-OHdG, is performed on the same urine samples,
then the creatinine or specific gravity term often cancels out and adjustment is not needed. For blood
analyses, normalizations are normally not performed as the blood volume is relatively constant.
If BPA induces oxidative stress as indicated, the mechanisms involved may be related to the
metabolism of BPA, which mainly occurs in hepatocytes. The principal BPA metabolism pathway is
direct phase II conjugation leading to a glucuronide [50], but a minor route entails cytochrome P-450
oxidation by hydroxylation to a catechol, followed by further transformation to an o-quinone through
a postulated bisphenol semiquinone RO• intermediate [5]. The catechol-o-quinone couple is capable
of redox cycling with the generation of ROS [51,52]. Peroxidase [4,5] and tyrosinase [53] were also
shown to oxidize BPA into a bisphenol quinone. In addition to oxidative stress, antioxidant depletion,
and effects on antioxidant enzymes, as reported in the papers included in this review, other mechanisms
have been suggested regarding BPA’s adverse effects, such as a pro-oxidant effect, mitochondrial
dysfunction, alteration in cell signaling pathways, and induction of cell death [3]. BPA has also been
shown to have both estrogenic and anti-androgenic effects, as well as potential anti-thyroid effects [54].
Humans are exposed to hundreds, if not thousands, of different xenobiotics simultaneously,
therefore, animal studies with controlled exposure, in which single chemicals and higher doses
can be studied, could contribute to identify suitable oxidative stress biomarkers from bisphenol
exposures, which thereafter can be measured in humans. Although none of the identified biomarkers
are considered BPA- or organ-specific, they can be assessed repeatedly and non-invasively in urine and
may capture disruptions at different biological levels and could help to understand causal relationships.
Int. J. Environ. Res. Public Health 2020, 17, 3609 22 of 28
5. Conclusions
From the last 12 years, 27 publications were identified that had investigated the oxidative stress
effect biomarkers in human studies of bisphenols. Of these, BPA had been mostly studied and
was most often measured in urine. Of the small molecule biomarkers, urinary measurements of
8-OHdG and MDA were most common, followed by 8-isoprostane and HNE-MA. However, MDA
has methodological and analytical issues, wherefore urinary or serum/plasma 8-OHdG, 8-isoprostane,
and HNE-MA appear to be the most reliable biomarkers of oxidative stress. There were found
dominantly positive associations between BPA and the oxidative stress biomarkers, but also equivocal
results, and only one negative association (on the antioxidant enzyme GPx). The finding that a single
xenobiotic such as BPA at relatively low exposure levels was predominantly positively associated
with increased levels of various biomarkers of oxidative stress is thought-provoking. However, if the
literature is not biased with studies reporting mainly positive associations, this may be a reality. None of
the biomarkers were specific for any of the bisphenols, and more studies, preferably longitudinal with
repeated samples taken and using the best available methodology for measuring the oxidative stress
biomarkers, are required to conclude whether they are causally linked to specific health outcomes.
However, it is well-documented that increased oxidative stress is associated with increased oxidative
damage causing DNA mutations, aging, etc.
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Appendix A.
Table A1. Used in the two Pubmed database searches performed at the turn of the year 2017–2018
(limited to years 2008–2017) and on 3 January, 2020, for the years 2018–2019.





(Bisphenol) AND (((((((((((((“Behavior”[Mesh]) OR (“Behavior and Behavior
Mechanisms”[Mesh] OR “Reproductive Behavior”[Mesh])) OR “Social Behavior
Disorders”[Mesh]) OR (“Child Behavior Disorders”[Mesh] OR “Adolescent Behavior”[Mesh]))
OR “Antisocial Personality Disorder”[Mesh]) OR (“Infant Behavior”[Mesh] OR “Spatial
Behavior”[Mesh])) OR “Sucking Behavior”[Mesh]) OR (“Sexual Behavior, Animal”[Mesh] OR
“Sexual Behavior”[Mesh])) OR (“Paternal Behavior”[Mesh] OR “Maternal Behavior”[Mesh] OR
“Impulsive Behavior”[Mesh] OR “Feeding Behavior”[Mesh] OR “Exploratory Behavior”[Mesh]))
OR (“Compulsive Behavior”[Mesh] OR “Child Behavior”[Mesh] OR “Behavior,
Animal”[Mesh])) OR “Mental Disorders”[Mesh])) OR (Behavior OR Neurobehavior OR
Neurodevelopment OR Neurology OR Parkinson OR Alzheimer OR Autism OR Hyperactivity
OR ASD OR ADHD OR mental retardation OR IQ loss OR internalizing OR externalizing))
Cancer
(Bisphenol) AND (((((((“Neoplasms”[Mesh] OR “Uterine Cervical Neoplasms”[Mesh] OR
“Urologic Neoplasms”[Mesh] OR “Liver Neoplasms”[Mesh] OR “Hereditary Breast and Ovarian
Cancer Syndrome”[Mesh] OR “Early Detection of Cancer”[Mesh]) OR (“Urogenital
Neoplasms”[Mesh] OR “Testicular Neoplasms”[Mesh] OR “Endometrial Neoplasms”[Mesh] OR
“Vaginal Neoplasms”[Mesh] OR “Uterine Neoplasms”[Mesh])) OR (“Prostatic
Neoplasms”[Mesh] OR “Ovarian Neoplasms”[Mesh] OR “Endocrine Gland Neoplasms”[Mesh]))
OR (“Breast Neoplasms”[Mesh] OR “Neoplasms, Germ Cell and Embryonal”[Mesh] OR “Tumor
Microenvironment”[Mesh])) OR (“Thyroid Neoplasms”[Mesh] OR “Pituitary
Neoplasms”[Mesh] OR “Brain Neoplasms”[Mesh]))) OR (Cancer OR hormone-dependent
cancer OR neoplasm OR malignant tumor OR tumor OR tumour) OR (Colon neoplasms))
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Table A1. Cont.
Health Endpoint Bisphenol AND (MeSH Terms OR synonym)
Endocrine diseases
(Bisphenol) AND (“Endocrine System”[Mesh] OR “Endocrine Glands”[Mesh] OR “Endocrine
System Diseases”[Mesh] OR “Hormones”[Mesh] OR “Gonadal Hormones”[Mesh] OR “Placental
Hormones”[Mesh] OR “Pituitary Hormones”[Mesh] OR “Growth Hormone”[Mesh] OR
“Thyroid Hormones”[Mesh] OR “Gastrointestinal Hormones”[Mesh] OR “Sex Hormone-Binding
Globulin”[Mesh] OR “Adrenocorticotropic Hormone”[Mesh] OR “Adrenal Cortex
Hormones”[Mesh] OR Endocrine system OR hypothyroidism OR hyperthyroidism OR adrenal)
Immune system and
allergy
(bisphenol) AND (“Allergy and Immunology”[Mesh] OR “Hypersensitivity”[Mesh] OR
“Rhinitis, Allergic, Seasonal”[Mesh] OR “Food Hypersensitivity”[Mesh] OR “Drug
Hypersensitivity”[Mesh] OR “Shellfish Hypersensitivity”[Mesh] OR Allergy OR Hypersensitive
OR respiratory allergy OR gastrointestinal allergy OR multiple chemical sensitivity OR allergic
hypersensitivity disease OR contact allergy OR “Immune System”[Mesh] OR “Immune System
Diseases”[Mesh] OR Immune system OR autoimmune disease OR cytokines OR white cells OR





(Bisphenol) AND (“Metabolic Syndrome”[Mesh] OR “Nutritional and Metabolic
Diseases”[Mesh] OR “Metabolic Diseases”[Mesh] OR “Metabolism”[Mesh] OR “Glucose
Metabolism Disorders”[Mesh] OR “Acidosis”[Mesh] OR “Metabolome”[Mesh] OR
“Metabolomics”[Mesh] OR “Receptor, Insulin”[Mesh] OR “Lipolysis”[Mesh] OR “Gout”[Mesh]
OR “Diabetes Mellitus, Type 2”[Mesh] OR “Acidosis, Renal Tubular”[Mesh] OR
“Homocysteinemia” [Supplementary Concept] OR “Peroxisome Proliferator-Activated Receptor
Gamma Coactivator 1-alpha”[Mesh] OR “Obesity”[Mesh] OR “Pediatric Obesity”[Mesh] OR
“Obesity, Abdominal”[Mesh] OR “Abdominal obesity metabolic syndrome” [Supplementary
Concept] OR “Cardiovascular System”[Mesh] OR “Cardiovascular Abnormalities”[Mesh] OR
“Pregnancy Complications, Cardiovascular”[Mesh] OR “Cardiovascular Diseases”[Mesh] OR
“Myocardial Infarction”[Mesh] OR obesity OR abdominal obesity OR waist hip ratio OR adipose
tissue OR adypokine OR visceral fat OR body fat OR overweight OR Metabolic OR Metabolic
disorder OR Metabolic syndrome OR glucose homeostasis OR Hyperlipidemia OR Dyslipidemia
OR hypertriglyceridemia OR HOMA-IR OR insulin resistance OR pancreas OR liver OR kidney)
Reproductive diseases
(Bisphenol) AND (reproductive OR puberty OR pregnancy OR infertility OR semen quality OR
placenta OR anogenital distance OR hypospadia OR cryptorchidism OR “Reproductive
Health”[Mesh] OR “Reproductive Medicine”[Mesh] OR “Reproduction”[Mesh] OR
“Reproductive Techniques, Assisted”[Mesh] OR “Infertility”[Mesh])
On 27 January, 2020, a complementary PubMed search using the broad search terms “bisphenol AND oxidative
stress, AND biomarker” was performed.
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Appendix B.1. Adverse Outcome Pathways (AOPs) and Key Events (KEs) Involving BPA or the Biomarkers of
Oxidative Stress Reported in the Human Studies (Accessed 15 April 2020)
BPA is listed as stressor 521 in AOPWiki, link: https://aopwiki.org/stressors/521. The only AOP
listed with BPA as a stressor is AOP 314: Activation of estrogen receptor in immune cells leading to
exacerbation of systemic lupus erythematosus (status: under development, included in OECD Work
Plan), link: https://aopwiki.org/aops/314.
Oxidative stress is listed as KE 1392, in AOP 17: Binding of electrophilic chemicals to SH
(thiol)-group of proteins and/or to seleno-proteins involved in protection against oxidative stress during
brain development leads to impairment of learning and memory (status: under development, included
in OECD Work Plan), link: https://aopwiki.org/aops/17, AOP 220: Cyp2E1 activation leading to liver
cancer (status: under review, included in OECD Work Plan), link: https://aopwiki.org/aops/220 and AOP
284: Binding of electrophilic chemicals to SH (thiol)-group of proteins and/or to seleno-proteins involved
in protection against oxidative stress leads to chronic kidney disease (status: under development), link:
https://aopwiki.org/aops/284.
ROS is mentioned in 26 AOPs (3, 17, 27, 37, 38, 41, 54, 144, 148, 149, 173, 207, 213, 216, 220, 238,
257, 260, 272, 277, 282, 293, 294, 296, 298, 311), link: https://aopwiki.org/aops?utf8=%E2%9C%93&
search=reactive+oxygen+species+&commit=Search&find_by_id= and in 2 KEs, link: https://aopwiki.
org/events?utf8=%E2%9C%93&search=reactive+oxygen+species+&commit=Search&find_by_id=.
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RNS is mentioned in 7 AOPs (37, 149, 173, 277, 293, 294, 296), link: https://aopwiki.org/aops?
utf8=%E2%9C%93&search=reactive+nitrogen+species+&commit=Search&find_by_id= and in 8 KEs,
link: https://aopwiki.org/events?utf8=%E2%9C%93&search=reactive+nitrogen+species+&commit=
Search&find_by_id=.
8-OHdG is mentioned in AOP 17: Binding of electrophilic chemicals to SH (thiol)-group of proteins
and/or to seleno-proteins involved in protection against oxidative stress during brain development leads
to impairment of learning and memory (status: under development, included in OECD Work Plan),
link: https://aopwiki.org/aops/17 and in AOP 296: Oxidative DNA damage leading to chromosomal
aberrations and mutations (status: under development), link: https://aopwiki.org/aops/296. It is also
listed in KE 1634, link: https://aopwiki.org/events?utf8=%E2%9C%93&search=8-OHdG&commit=
Search&find_by_id=.
8-isoprostane is mentioned in KE 1498, link: https://aopwiki.org/events?utf8=%E2%9C%93&
search=8-isoprostane&commit=Search&find_by_id=.
MDA is mentioned in AOP 220: Chronic Cyp2E1 activation leading to liver cancer (status:
under review, included in OECD Work Plan), link: https://aopwiki.org/aops/220#stressors and AOP
260: CYP2E1 activation and formation of protein adducts leading to neurodegeneration (status:
under development), link: https://aopwiki.org/aops/260. MDA is also listed in 3 KEs, link: https:
//aopwiki.org/events?utf8=%E2%9C%93&search=malondialdehyde&commit=Search&find_by_id=.
TBARS/TBA is mentioned in AOP 17: Binding of electrophilic chemicals to SH (thiol)-group
of proteins and/or to seleno-proteins involved in protection against oxidative stress during
brain development leads to impairment of learning and memory (status: under development,
included in OECD Work Plan), link: https://aopwiki.org/aops/17, AOP 220: Chronic Cyp2E1
activation leading to liver cancer (status: under review, included in OECD Work Plan), link:
https://aopwiki.org/aops/220#stressors and AOP 260: CYP2E1 activation and formation of protein
adducts leading to neurodegeneration (status: under development), link: https://aopwiki.org/aops/260.
TBARS is also listed in 4 KEs, links: https://aopwiki.org/events?utf8=%E2%9C%93&search=
TBARS&commit=Search&find_by_id= and https://aopwiki.org/events?utf8=%E2%9C%93&search=
TBA&commit=Search&find_by_id=.
4-HNE is listed in AOP 149: Peptide oxidation leading to hypertension (status: under development,
included in OECD Work Plan), link: https://aopwiki.org/aops/149 and AOP 260: CYP2E1 activation
and formation of protein adducts leading to neurodegeneration (status: under development), link:
https://aopwiki.org/aops/260, and in 2 KEs, link: https://aopwiki.org/events?utf8=%E2%9C%93&
search=4-hydroxy-2-nonenal+&commit=Search&find_by_id=.
3-Nitro-tyrosine is mentioned in AOP 188: Iodotyrosine deiodinase (IYD) inhibition leading to
altered amphibian metamorphosis (status: under development), link https://aopwiki.org/aops/188.
COX2 is listed in 8 AOPs (3, 21, 43, 149, 150, 277, 293, 294), link: https://aopwiki.org/aops?utf8=
%E2%9C%93&search=Cyclooxygenase+2&commit=Search&find_by_id= and in 4 KEs, link: https:
//aopwiki.org/events?utf8=%E2%9C%93&search=cyclooxygenase+2&commit=Search&find_by_id=.
CAT is listed in 5 AOPs (17, 37, 131, 148, 296), link: https://aopwiki.org/aops?utf8=%E2%9C%93&
search=catalase&commit=Search&find_by_id= and in 3 KEs, link: https://aopwiki.org/events?utf8=
%E2%9C%93&search=catalase&commit=Search&find_by_id=.
SOD is mentioned in 6 AOPs (17, 46, 48, 220, 296, 301), link: https://aopwiki.org/
aops?utf8=%E2%9C%93&search=superoxide+dismutase+&commit=Search&find_by_id= and in 4
KEs, link: https://aopwiki.org/events?utf8=%E2%9C%93&search=superoxide+dismutase+&commit=
Search&find_by_id=.
GPx1 is listed in 4 AOPs (4, 119, 209, 271) and 5 KEs, link: https://aopkb.oecd.org/search.ashx?
qry=erythrocyte+glutathione+peroxidase.
GR is listed in 7 AOPs (120, 124, 187, 209, 289, 305, 1573) and 12 KEs, link: https://aopkb.oecd.org/
search.ashx?qry=glutathione+reductase+.
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TrxR is mentioned in AOP 17: Binding of electrophilic chemicals to SH (thiol)-group of proteins
and/or to seleno-proteins involved in protection against oxidative stress during brain development leads
to impairment of learning and memory (status: under development, included in OECD Work Plan),
link: https://aopwiki.org/aops/17 and is listed in 6 other AOPs (120, 124, 187, 289, 305, 1573) and 8 KEs,
link: https://aopkb.oecd.org/search.ashx?qry=thioredoxin+reductase+&sort=0.
GSH is listed in 15 AOPs (3, 17, 31, 37, 46, 144, 148, 149, 205, 209, 220, 260, 293, 294, 296),
link: https://aopwiki.org/aops?utf8=%E2%9C%93&search=glutathione&commit=Search&find_by_id=,
3 KEs, link: https://aopwiki.org/events?utf8=%E2%9C%93&search=glutathione&commit=Search&
find_by_id=, and one other KE, link: https://aopwiki.org/events/130.
Se is listed in AOP 17: Binding of electrophilic chemicals to SH (thiol)-group of proteins and/or
to seleno-proteins involved in protection against oxidative stress during brain development leads
to impairment of learning and memory (status: under development, included in OECD Work Plan),
link: https://aopwiki.org/aops/17 and AOP 284: Binding of electrophilic chemicals to SH (thiol)-group
of proteins and/or to seleno-proteins involved in protection against oxidative stress leads to chronic
kidney disease (status: under development), link: https://aopwiki.org/aops/284.
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